World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
26006
World Ranking
16562
National Ranking
8321

Overview

Stephen M. Hahn is affiliated with The University of Texas Health Science Center at Houston in the United States. Their research is situated primarily within the field of Medicine, with a focus on several subfields including Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, General Health Professions, Radiation, and Oncology.

The topics most frequently addressed in their work cover Advances in Oncology and Radiotherapy, Advanced Radiotherapy Techniques, Lung Cancer Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, Radiation Dose and Imaging, Vaccine Coverage and Hesitancy, and Ethics and Legal Issues in Pediatric Healthcare.

Recent scholarly papers authored or co-authored by Stephen M. Hahn include:

  • Global Radiotherapy: Current Status and Future Directions-White Paper, 2021, JCO Global Oncology
  • Unwavering Regulatory Safeguards for COVID-19 Vaccines, 2020, JAMA
  • Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy, 2020, Clinical Cancer Research
  • Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity, 2020, Journal of Surgical Oncology
  • NTCP Models for Severe Radiation Induced Dermatitis After IMRT or Proton Therapy for Thoracic Cancer Patients, 2020, Frontiers in Oncology

Frequent co-authors collaborating with Stephen M. Hahn include Charles B. Simone, Zhongxing Liao, Mary Gospodarowicz, Peter Marks, and Abigail T. Berman.

The publication venues where their research appears most often are JAMA, International Journal of Radiation Oncology*Biology*Physics, JCO Global Oncology, Clinical Cancer Research, and Journal of Surgical Oncology.

Best Publications

  • Photodynamic therapy of cancer: An update†‡

    Patrizia Agostinis;Kristian Berg;Keith A. Cengel;Thomas H. Foster

  • Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

    Christina Twyman-Saint Victor;Andrew J. Rech;Amit Maity;Ramesh Rengan;Ramesh Rengan

  • Improving immune-vascular crosstalk for cancer immunotherapy

    Yuhui Huang;Betty Y.S. Kim;Charles K. Chan;Stephen M. Hahn

  • Hypoxia is important in the biology and aggression of human glial brain tumors.

    Sydney M. Evans;Kevin D. Judy;Isolde Dunphy;W. Timothy Jenkins

  • National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22–24, 2009

    Carmen J. Allegra;Denise R. Aberle;Pamela Ganschow;Stephen M. Hahn

  • Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer

    Zhongxing Liao;J. Jack Lee;Ritsuko Komaki;Daniel R. Gomez

  • Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.

    Timothy C. Zhu;Jarod C. Finlay;Stephen M. Hahn

  • Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.

    Xiaohong Wang;Jonathan E. Schoenhals;Ailin Li;David R. Valdecanas

  • A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy

    James M. Metz;Debbie Smith;Rosemarie Mick;Robert Lustig

  • Detection of Hypoxia in Human Squamous Cell Carcinoma by EF5 Binding

    Sydney M. Evans;Stephen Hahn;Deirdre R. Pook;W. Timothy Jenkins

  • Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding.

    Sydney M. Evans;Kevin D. Judy;Isolde Dunphy;W. Timothy Jenkins

  • Short-term and long-term health risks of nuclear-power-plant accidents

    John P. Christodouleas;Robert D. Forrest;Christopher G. Ainsley;Zelig Tochner

  • Factors Affecting the Risk of Brain Metastases After Definitive Chemoradiation for Locally Advanced Non–Small-Cell Lung Carcinoma

    Theodore J. Robnett;Mitchell Machtay;James P. Stevenson;Kenneth M. Algazy

  • In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model.

    Periannan Kuppusamy;Mobae Afeworki;Ravi A. Shankar;Deborah Coffin

  • Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage.

    Amram Samuni;Dorit Winkelsberg;Ariè Pinson;Stephen M. Hahn

  • Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.

    Quynh-Nhu Nguyen;Stephen G. Chun;Edward Chow;Ritsuko Komaki

  • Detection of Brain Tumor Cells in the Peripheral Blood by a Telomerase Promoter-Based Assay

    Kelly M. MacArthur;Gary D. Kao;Sanjay Chandrasekaran;Michelle Alonso-Basanta

  • Farnesyltransferase Inhibitors An Overview of the Results of Preclinical and Clinical Investigations

    Thomas B. Brunner;Stephen M. Hahn;Anjali K. Gupta;Ruth J. Muschel

  • The RAS signal transduction pathway and its role in radiation sensitivity

    W Gillies McKenna;Ruth J Muschel;Anjali K Gupta;Stephen M Hahn

  • Nelfinavir Down-regulates Hypoxia-Inducible Factor 1α and VEGF Expression and Increases Tumor Oxygenation: Implications for Radiotherapy

    Nabendu Pore;Anjali K. Gupta;George J. Cerniglia;Zibin Jiang

Frequent Co-Authors

Eli Glatstein
Eli Glatstein University of Pennsylvania
Rosemarie Mick
Rosemarie Mick University of Pennsylvania
Arjun G. Yodh
Arjun G. Yodh University of Pennsylvania
Cameron J. Koch
Cameron J. Koch University of Pennsylvania
Douglas L. Fraker
Douglas L. Fraker University of Pennsylvania
James B. Mitchell
James B. Mitchell National Institutes of Health
William DeGraff
William DeGraff National Institutes of Health
Ruth J. Muschel
Ruth J. Muschel University of Oxford
Corey J. Langer
Corey J. Langer University of Pennsylvania
Andy J. Minn
Andy J. Minn University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If studying Medicine in the USA feels overwhelming or out of reach, there are other rewarding pathways in healthcare to consider. For many, nursing is a popular option. You may want to explore whats the easiest nursing program to get into?, especially if you are looking for a flexible entry point. Some schools offer greater accessibility, such as nursing school that does not require teas test, removing additional barriers in the admissions process.

Alternatively, you can pursue fast-growing fields that require less time to get started, like medical billing and coding. These programs are available online, and you can find valuable support by searching for financial aid for medical billing and coding programs.

If you're interested in leadership or administration, consider enrolling in a healthcare administration accelerated degree online. These career pathways offer diverse opportunities within the healthcare industry, often with flexible learning options suited for busy students or working professionals.

Best Scientists Citing Stephen M. Hahn

Trending Scientists